AOD-9604
peptideGrowth-hormone fragment
Research status · Not FDA-approved
Not FDA-approved. FDA has flagged safety concerns (including immunogenicity) and it is not permitted for compounding. Human fat-loss evidence is weak.
AOD-9604 is a fragment of the growth-hormone molecule marketed in fat-loss contexts. It is not approved, and clinical fat-loss evidence in humans is weak. Worth a frank clinician conversation about whether it adds anything over fundamentals.
How it works
A GH fragment proposed to influence fat metabolism without the full growth-promoting effects of GH; human effect size is unclear.
Commonly discussed use cases
- Fat loss (discussed, weak evidence)
Supposed / potential benefits
- Claimed fat-metabolism effects not well supported by human trials
Common side effects
- Injection-site reactions
- Headache (reported)
- Limited long-term safety data
Warnings & contraindications
- Not FDA-approved; FDA flagged for compounding due to safety concerns
- Unregulated products carry identity/purity risks
Typical timing considerations
No established regimen; any use should be clinician-directed.
Administration route
Subcutaneous injection
Storage
Refrigerate after reconstitution; follow instructions.
Questions to ask your clinician
- Given weak evidence, is this worth it over diet/training fundamentals?
- What are the safety concerns FDA raised?
Commonly tracked in Reta
Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.
Track this in Reta
Beta members get a ready-made tracker for AOD-9604 — schedule, dose log, injection-site rotation, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.
Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.